rubidium chloride rb-82

Small moleculeapproved

Approved

Dec 29, 1989

Rubidium Rb-82 is a radioactive isotope of rubidium. It is widely used for Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease. Rb-82 decays by positron emission and associated gamma emission with a physical half-life of 75 seconds. In biochemical behavior, it is analogous to potassium ion (K+) and is rapidly extracted by the myocardium proportional to the blood flow. Rb+ participates in the sodium-potassium (Na+/K+) ion exchange pumps that are present in cell membranes. 82 radioactivity in viable myocardium is higher than in infarcted tissue, reflecting intracellular retention. Rubidium 82 chloride was approved by the FDA and is marketed under a trade name Ruby-Fill and Cardiogen-82. — NCATS

Clinical trial activity

10 trials · 11 clinical orgs · 3 marketing orgs

Phase 1
1
Phase 2
4
Phase 3
1
Phase 4
2

Earliest trial started Nov 1, 2006 (NCT01254591)

Timeline

1980s

  1. Dec 29, 1989

    Bracco — Earliest FDA Approval

  2. Dec 29, 1989

    Bracco — NDA Secondary Org

  3. Dec 29, 1989

    Bracco — NDA Organization

2010s

  1. Jan 1, 2011

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2011

    Earliest Phase 3 Sponsor(trial)

  3. Sep 30, 2016

    Jubilant DraxImage Inc. — NDA Secondary Org

  4. Sep 30, 2016

    Jubilant DraxImage Inc. — Marketing Organization

  5. Sep 30, 2016

    Jubilant Innovation Ltd. — NDA Secondary Org

  6. Jan 1, 2017

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Approval history

  • approvedDec 29, 1989

Chemistry & pharmacology

Loading structure…

SMILES

[Cl-].[Rb+]
Mol. weight
120.92 g/mol
Chirality
Achiral Molecule
Inorganic
Yes
Polymer
No
Delivery
Parenteral
Availability
Prescription Only

Oral

No

Parenteral

Yes

Topical

No

Black box warning

Sources

Also known as

  • 82rbcl
  • 82rbcl
  • cardiogen
  • cardiogen
  • cardiogen-82
  • cardiogen-82
  • cardiogen-82
  • cardiogen-82
  • cardiogen-82
  • rb82
  • rb-82
  • rubidium
  • rubidium
  • rubidium-82
  • rubidium-82
  • rubidium-82 chloride
  • rubidium (82rb) chloride
  • rubidium (82rb) chloride
  • rubidium (82rb) chloride
  • rubidium chloride
  • rubidium chloride
  • rubidium chloride (82rb)
  • rubidium chloride (82rb)
  • rubidium chloride rb 82
  • rubidium chloride rb 82
  • rubidium chloride rb 82
  • rubidium chloride rb-82
  • rubidium chloride rb-82
  • rubidium rb-82 chloride
  • rubidium rb-82 chloride
  • rubidium rb-82 chloride
  • rubidium rb-82 chloride
  • ruby-fill

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06965621Phase 2Nov 30, 2025Illumina, Inc., University of Texas, Galveston
NCT05286593Phase 4Dec 28, 2021Bracco, Ochsner Health System
NCT03236311Phase 2Oct 12, 2017Sanofi
NCT03048097Phase 2Feb 1, 2017Yale University
NCT01919450Phase 4Jul 1, 2013Cardiovascular Imaging Technologies
NCT01679886N/ASep 1, 2012University of Paris
NCT01648933N/AJul 1, 2012University of Paris
NCT01433705Phase 1Nov 1, 2011University of Michigan
NCT01379677Phase 3Feb 1, 2011Advanced Accelerator Applications, University of London
NCT01254591N/ANov 1, 2006University of London
Showing 10 of 10 trials
Page 1 / 1

Organizations

Research & Development (11)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of LondonAcademic/Hospital2122006
University of ParisAcademic/Hospital2212012
Advanced Accelerator ApplicationsFor profit1112011
BraccoFor profit1012021
Cardiovascular Imaging TechnologiesFor profit1112013
Illumina, Inc.For profit1112025
Ochsner Health SystemAcademic/Hospital1112021
SanofiFor profit1112017
University of MichiganAcademic/Hospital1112011
University of Texas, GalvestonAcademic/Hospital1012025
Yale UniversityAcademic/Hospital1112017
11 organizations
Page 1 / 1

Marketing (5)

OrganizationOrg typeRelationshipDate
BraccoFor profitNDA2Dec 29, 1989
BraccoFor profitNDADec 29, 1989
Jubilant DraxImage Inc.For profitNDA2Sep 30, 2016
Jubilant DraxImage Inc.For profitMKTGSep 30, 2016
Jubilant Innovation Ltd.For profitNDA2Sep 30, 2016